BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27

• Press Releases

  Biote Schedules Fourth Quarter and Full Year 2025 Financial Results Release and Conference Call

  February 26, 2026

   · 

  3 min read
• Press Releases

  MindRank Announces First Patient Dosed in Phase III Trial of AI-Designed Oral GLP-1 Receptor Agonist MDR-001

  February 26, 2026

   · 

  3 min read
• Press Releases

  Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering

  February 26, 2026

   · 

  4 min read
• Press Releases

  Palvella Therapeutics Announces Pricing of Upsized Public Offering

  February 26, 2026

   · 

  5 min read
• Press Releases

  InnoCare Announces Key Developments of Critical Clinical Studies

  February 26, 2026

   · 

  3 min read
• Press Releases

  Thermo Fisher Scientific Increases Quarterly Dividend

  February 26, 2026

   · 

  1 min read
• Press Releases

  FDA Approves NUMELVI™ (atinvicitinib tablets) for Dogs from Merck Animal Health – The First and Only Second-Generation Janus Kinase (JAK) Inhibitor for the Control of Pruritus Associated with Allergic Dermatitis

  February 26, 2026

   · 

  8 min read
• Press Releases

  argenx Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update

  February 26, 2026

   · 

  15 min read
• Press Releases

  argenx Announces Positive Topline Results from Phase 3 ADAPT OCULUS Trial of VYVGART in Ocular Myasthenia Gravis

  February 26, 2026

   · 

  13 min read
• Press Releases

  Idorsia reports strong 2025 results with QUVIVIQ sales more than doubling – further sales growth ahead with multiple pipeline catalysts in 2026

  February 26, 2026

   · 

  10 min read